PMID- 35145233 OWN - NLM STAT- MEDLINE DCOM- 20220411 LR - 20220711 IS - 1476-5594 (Electronic) IS - 0950-9232 (Print) IS - 0950-9232 (Linking) VI - 41 IP - 13 DP - 2022 Mar TI - Mesenchymal stromal cells equipped by IFNalpha empower T cells with potent anti-tumor immunity. PG - 1866-1881 LID - 10.1038/s41388-022-02201-4 [doi] AB - Cancer treatments have been revolutionized by the emergence of immune checkpoint blockade therapies. However, only a minority of patients with various tumor types have benefited from such treatments. New strategies focusing on the immune contexture of the tumor tissue microenvironment hold great promises. Here, we created IFNalpha-overexpressing mesenchymal stromal cells (IFNalpha-MSCs). Upon direct injection into tumors, we found that these cells are powerful in eliminating several types of tumors. Interestingly, the intra-tumoral injection of IFNalpha-MSCs could also induce specific anti-tumor effects on distant tumors. These IFNalpha-MSCs promoted tumor cells to produce CXCL10, which in turn potentiates the infiltration of CD8(+) T cells in the tumor site. Furthermore, IFNalpha-MSCs enhanced the expression of granzyme B (GZMB) in CD8(+) T cells and invigorated their cytotoxicity in a Stat3-dependent manner. Genetic ablation of Stat3 in CD8(+) T cells impaired the effect of IFNalpha-MSCs on GZMB expression. Importantly, the combination of IFNalpha-MSCs and PD-L1 blockade induced an even stronger anti-tumor immunity. Therefore, IFNalpha-MSCs represent a novel tumor immunotherapy strategy, especially when combined with PD-L1 blockade. CI - (c) 2022. The Author(s). FAU - Zhang, Tao AU - Zhang T AD - CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China. FAU - Wang, Yu AU - Wang Y AUID- ORCID: 0000-0002-7309-7304 AD - CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China. FAU - Li, Qing AU - Li Q AD - CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China. FAU - Lin, Liangyu AU - Lin L AUID- ORCID: 0000-0003-4312-8955 AD - CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China. FAU - Xu, Chunliang AU - Xu C AUID- ORCID: 0000-0002-4514-8477 AD - CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China. FAU - Xue, Yueqing AU - Xue Y AD - CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China. FAU - Hu, Mingyuan AU - Hu M AD - CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China. FAU - Shi, Yufang AU - Shi Y AUID- ORCID: 0000-0001-9716-2126 AD - CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China. yufangshi@sibs.ac.cn. AD - The Third Affiliated Hospital of Soochow University, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine, Soochow University Medical College, Suzhou, Jiangsu, 215123, China. yufangshi@sibs.ac.cn. FAU - Wang, Ying AU - Wang Y AUID- ORCID: 0000-0002-2571-9367 AD - CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China. yingwang@sibs.ac.cn. LA - eng PT - Journal Article DEP - 20220210 PL - England TA - Oncogene JT - Oncogene JID - 8711562 RN - 0 (B7-H1 Antigen) RN - 0 (Interferon-alpha) SB - IM MH - B7-H1 Antigen/metabolism MH - CD8-Positive T-Lymphocytes MH - Cell Line, Tumor MH - Humans MH - Immunotherapy MH - Interferon-alpha MH - *Mesenchymal Stem Cells/metabolism MH - *Neoplasms/metabolism/therapy MH - Tumor Microenvironment PMC - PMC8956510 COIS- The authors declare no competing interests. EDAT- 2022/02/12 06:00 MHDA- 2022/04/12 06:00 PMCR- 2022/02/10 CRDT- 2022/02/11 05:35 PHST- 2021/08/10 00:00 [received] PHST- 2022/01/19 00:00 [accepted] PHST- 2021/12/22 00:00 [revised] PHST- 2022/02/12 06:00 [pubmed] PHST- 2022/04/12 06:00 [medline] PHST- 2022/02/11 05:35 [entrez] PHST- 2022/02/10 00:00 [pmc-release] AID - 10.1038/s41388-022-02201-4 [pii] AID - 2201 [pii] AID - 10.1038/s41388-022-02201-4 [doi] PST - ppublish SO - Oncogene. 2022 Mar;41(13):1866-1881. doi: 10.1038/s41388-022-02201-4. Epub 2022 Feb 10.